Gut Microbiota and the Paradox of Cancer Immunotherapy
Author(s)
Poutahidis, Theofilos; Kleinewietfeld, Markus; Erdman, Susan E.
DownloadPoutahidis-2014-Gut Microbiota and t.pdf (666.0Kb)
PUBLISHER_POLICY
Publisher Policy
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Terms of use
Metadata
Show full item recordAbstract
It is recently shown that beneficial environmental microbes stimulate integrated immune and neuroendocrine factors throughout the body, consequently modulating regulatory T-lymphocyte phenotypes, maintaining systemic immune balance, and determining the fate of preneoplastic lesions toward regression while sustaining whole body good health. Stimulated by a gut microbiota-centric systemic homeostasis hypothesis, we set out to explore the influence of the gut microbiome to explain the paradoxical roles of regulatory T-lymphocytes in cancer development and growth. This paradigm shift places cancer prevention and treatment into a new broader context of holobiont engineering to cultivate a tumor-suppressive macroenvironment.
Date issued
2014-04Department
Massachusetts Institute of Technology. Division of Comparative MedicineJournal
Frontiers in Immunology
Publisher
Frontiers Research Foundation
Citation
Poutahidis, Theofilos, Markus Kleinewietfeld, and Susan E. Erdman. “Gut Microbiota and the Paradox of Cancer Immunotherapy.” Front. Immunol. 5 (April 7, 2014).
Version: Final published version
ISSN
1664-3224